Successful delivery in patients with FXIII deficiency receiving prophylaxis: Report of 17 cases in Iran

Haemophilia

Volumn 18, Issue 5, 2012, Pages 773-776

  Naderi, M ^a   Eshghi, P ^b   Cohan, N ^c   Miri Moghaddam, E ^d   Yaghmaee, M ^e   Karimi, M ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abortion; Bleeding score; Delivery; FXIII deficiency; Iran

Indexed keywords

BLOOD CLOTTING FACTOR 13 CONCENTRATE;

ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DELIVERY; FEMALE; HUMAN; IRAN; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DELIVERY, OBSTETRIC; FACTOR XIII; FACTOR XIII DEFICIENCY; FEMALE; HEMORRHAGE; HUMANS; IRAN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES;

EID: 84865572766     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02785.x     Document Type: Article

References (16)

1. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost 2009; 35: 426-38.
2. Muszbek L, Bagoly Z, Bereczky Z, Katona E. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis. Cardiovasc Hematol Agents Med Chem 2008; 6: 190-205.
3. Ichinose A. Physiopathology and regulation offactor XIII. Thromb Haemost 2001; 86: 57-65.
4. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 2003; 102: 4410-2.
5. Dardik R, Loscalzo J, Inbal A. Factor XIII (FXIII) and angiogenesis. J ThrombHaemost 2006; 4: 19-25.
6. Muszbek L, Bagoly Z. Fibrin formation disorders and pregnancy loss. Thromb Res 2007; 119(Suppl. 1): S69-70.
7. Anwar T, Miloszewski K. Factor XIII deficiency. Br J Haematol 1999; 107: 468-84.
8. Asahina T, Kobayashi T, Okada Y, Goto J, Terao T. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 2000; 21: 388-93.
9. Asahina T, Kobayashi T, Takeuchi K, Kanayama N. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 2007; 62: 255-60.
10. Inbal A, Muszbek L. Coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost 2003; 29: 171-4.
11. Karimi M, Cohan N. Factor XIII deficiency; review of literatures. IJBC 2010; 2: 179-87.
12. Eshghi P, Cohan N, Lak M et al. Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran. Clin Appl Thromb Hemost 2012; 18: 100-3.
13. Tosetto A, Rodeghiero F, Castaman G et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
14. Gootenberg JE. Factor concentrates for the treatment of factor XIII deficiency. Curr Opin Hematol 1998; 5: 372-5.
15. Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990; 29: 235-8.
16. Burrows RF, Ray JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv 2000; 55: 103-8.